Fundación Grupo Efecto Positivo Opposition, Dolutegravir Pediatric Combination, (P20210101732 (Ar122720 A1))
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Fundación Grupo Efecto Positivo (FGEP) opposition, Dolutegravir pediatric dispersible tablet, (P20210101730 (AR122718A1) )
Countries: Argentina Date: 2025
-
Fundación Grupo Efecto Positivo opposition, Lenacapavir, (AR109364A1)
Countries: Argentina Date: 2022
-
Fundación Grupo Efecto Positivo opposition, Tenofovir Alafenamide Fumarate , (P2012103681 (AR088109A1) )
Countries: Argentina Date: 2020
-
Fundación Grupo Efecto Positivo opposition, Doravirine (NNRTI), (ARP110101028)
Countries: Argentina Date: 2021
-
Fundación Grupo Efecto Positivo opposition, Lenacapavir, (AR118856 )
Countries: Argentina Date: 2022
-
Fundación Grupo Efecto Positivo opposition, Islatravir , (AR107596 (WO2017/139519) )
Countries: Argentina Date: 2020
-
Fundación Grupo Efecto Positivo opposition, Tenofovir 300mg+ Emtricitabina 200mg (TDF+FTC), (n/a)
Countries: Argentina Date: 2015
-
Fundación Grupo Efecto Positivo opposition, Sofosbuvir, (WO/2008/121634)
Countries: Argentina Date: 2015
-
Fundación Grupo Efecto Positivo opposition, Remdesivir, (WO2016069826 (A1))
Countries: Argentina Date: 2020
-
Fundación Grupo Efecto Positivo opposition, Molnupiravir (MK-4482), (AR12285A1)
Countries: Argentina Date: 2022